Southpoint Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-600,000	Closed	-$111M	–	45
2024 Q4	$111M	Sell	600,000 -69,976	-10%	-$13.5M	2.6%	21
2024 Q3	$132M	Sell	669,976 -480,024	-42%	-$99.8M	3.13%	11
2024 Q2	$238M	Buy	1,150,000 +450,000	+64%	+$102M	5.91%	3
2024 Q1	$190M	Sell	700,000 -300,000	-30%	-$71.6M	3.75%	9
2023 Q4	$236M	Buy	1,000,000 +200,000	+25%	+$39.3M	5.08%	4
2023 Q3	$157M	Buy	800,000 +400,000	+100%	+$82.1M	3.5%	11
2023 Q2	$84.1M	Hold	400,000	–	–	1.82%	22
2023 Q1	$80.7M	Buy	+400,000	New	+$90.7M	1.83%	21
2022 Q4	–	Sell	-500,000	Closed	-$98.4M	–	55
2022 Q3	$98.4M	Buy	500,000 +100,000	+25%	+$21.6M	2.65%	15
2022 Q2	$85.6M	Buy	+400,000	New	+$97.7M	2.43%	17